Masimo is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors.

 
  • Embrace the Wireless Movement with Tetherless Pulse Oximetry
  • Harnessing the power of industry-leading Masimo SET® measure-through motion technology, Radius™ PPG enhances clinician workflows and improves patient comfort and convenience with reliable, tetherless monitoring on the move.
 
  • UniView™
  • Intelligent Display for Next Generation Data Aggregation and Alarm Visualization
 
 
  • Rad-67™ Spot-check Monitoring Pulse CO-Oximeter®
  • More Than a Conventional Pulse Oximeter
 
  • CCHD Screening
  • Reliable, Accurate Screening for Critical Congenital Heart Disease (CCHD) with Masimo SET®

News & Media

 
  • August 15, 2019
  • Irvine, California
  • Masimo (NASDAQ: MASI), a global leader in innovative noninvasive monitoring technologies, today announced it has closed on a strategic investment with TNI medical AG (“TNI”), a privately held, commercial-stage medical device company headquartered in […]
  • August 7, 2019
  • Neuchatel, Switzerland
  • Masimo (NASDAQ: MASI) announced today that in a study published in the Journal of Clinical Monitoring and Computing, researchers investigated the effects of implementing a hospital-wide fluid and blood administration protocol using two Masimo measure […]
  • August 5, 2019
  • Neuchatel, Switzerland
  • Masimo (NASDAQ: MASI) announced today the CE marking of SpHb®, noninvasive and continuous hemoglobin monitoring, for neonatal and infant patients (< 3 kg). With this clearance, the benefits of SpHb are available for patients of all ages in CE mark co […]

Discover More at Masimo

 
  • March 2, 2018
  • Masimo Personal Health
  • MightySat is for people who want to improve their health, wellness, or fitness by providing key measurements that are more accurate & not available on other health and wellness devices. […]
  • February 23, 2018
  • Patient Safety Movement
  • The Patient Safety Movement Foundation believes reaching ZERO preventable deaths in hospitals by 2020 (0X2020™) is not only the right goal, but an attainable one with the […]
  • June 4, 2018
  • 2017 Masimo Annual Report
  • 2017 Masimo Annual Report - Automating Care. Reflecting on the Past and Defining the Future. […]

Next Generation SedLine is not licensed for sale in Canada.

Caution: Federal (USA) law restricts this device to sale by or on the order of a physician. See instructions for use for full prescribing information, including indications, contraindications, warnings, and precautions.

Improving Patient Outcomes and Reducing the Cost of Care®

© 2019 Masimo. All Rights Reserved.